Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-11-26 12:06:452024-11-26 12:06:45Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants
